NCT06923124View on ClinicalTrials.gov

A Study to Describe a Group of Spanish Patients With FMF and to Identify Suboptimally Treated Patients With Minimal Disease Activity and Its Impact on Quality of Life

CompletedOBSERVATIONAL
Enrollment

44

Participants

Timeline

Start Date

March 30, 2023

Primary Completion Date

May 28, 2024

Study Completion Date

May 28, 2024

Conditions
Familial Mediterranean Fever
Trial Locations (1)

07936

Novartis, East Hanover

Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY

NCT06923124 - A Study to Describe a Group of Spanish Patients With FMF and to Identify Suboptimally Treated Patients With Minimal Disease Activity and Its Impact on Quality of Life | Biotech Hunter | Biotech Hunter